Cargando…

Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort

Background: The toll of tuberculous meningitis (TBM) in both mortality and disability is considerable, but advancements in rehabilitation have the potential to improve the functional abilities and the quality of survivors’ lives. However, the typical phenotype of neurocognitive impairment in TBM sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Quinn, Carson M, Kasibante, John, Namudde, Alice, Bangdiwala, Ananta S, Kabahubya, Mable, Nakasujja, Noeline, Lofgren, Sarah, Elliott, Alison, Boulware, David R, Meya, David B, Cresswell, Fiona V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334841/
https://www.ncbi.nlm.nih.gov/pubmed/35949653
http://dx.doi.org/10.12688/wellcomeopenres.16967.2
_version_ 1784759195174699008
author Quinn, Carson M
Kasibante, John
Namudde, Alice
Bangdiwala, Ananta S
Kabahubya, Mable
Nakasujja, Noeline
Lofgren, Sarah
Elliott, Alison
Boulware, David R
Meya, David B
Cresswell, Fiona V
author_facet Quinn, Carson M
Kasibante, John
Namudde, Alice
Bangdiwala, Ananta S
Kabahubya, Mable
Nakasujja, Noeline
Lofgren, Sarah
Elliott, Alison
Boulware, David R
Meya, David B
Cresswell, Fiona V
author_sort Quinn, Carson M
collection PubMed
description Background: The toll of tuberculous meningitis (TBM) in both mortality and disability is considerable, but advancements in rehabilitation have the potential to improve the functional abilities and the quality of survivors’ lives. However, the typical phenotype of neurocognitive impairment in TBM survivors remains unstudied in HIV-predominant populations in sub-Saharan Africa. Methods: We tested 36 survivors of TBM in Uganda with a comprehensive battery of neurocognitive assessments at 8 and 24 weeks after diagnosis, and compared results to a representative cohort of HIV-uninfected Ugandans. Results: While participants had a broad range of impairments at eight weeks, there was marked improvement by 24 weeks, when a phenotype of impairment including deficits in motor functioning, verbal learning and memory, processing speed, and executive function emerged. These deficits were present despite good clinician-rated functional status. The majority (23/27, 85%) had evidence of moderate to severe depression at week 8, and at week 24 (18/24, 75%). Conclusion: These findings highlight the need for more comprehensive neurocognitive assessment in the survivors of TBM, and further investment in and study of rehabilitation, including management of depression, to improve long-term outcomes in this population.
format Online
Article
Text
id pubmed-9334841
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-93348412022-08-09 Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort Quinn, Carson M Kasibante, John Namudde, Alice Bangdiwala, Ananta S Kabahubya, Mable Nakasujja, Noeline Lofgren, Sarah Elliott, Alison Boulware, David R Meya, David B Cresswell, Fiona V Wellcome Open Res Research Article Background: The toll of tuberculous meningitis (TBM) in both mortality and disability is considerable, but advancements in rehabilitation have the potential to improve the functional abilities and the quality of survivors’ lives. However, the typical phenotype of neurocognitive impairment in TBM survivors remains unstudied in HIV-predominant populations in sub-Saharan Africa. Methods: We tested 36 survivors of TBM in Uganda with a comprehensive battery of neurocognitive assessments at 8 and 24 weeks after diagnosis, and compared results to a representative cohort of HIV-uninfected Ugandans. Results: While participants had a broad range of impairments at eight weeks, there was marked improvement by 24 weeks, when a phenotype of impairment including deficits in motor functioning, verbal learning and memory, processing speed, and executive function emerged. These deficits were present despite good clinician-rated functional status. The majority (23/27, 85%) had evidence of moderate to severe depression at week 8, and at week 24 (18/24, 75%). Conclusion: These findings highlight the need for more comprehensive neurocognitive assessment in the survivors of TBM, and further investment in and study of rehabilitation, including management of depression, to improve long-term outcomes in this population. F1000 Research Limited 2022-03-03 /pmc/articles/PMC9334841/ /pubmed/35949653 http://dx.doi.org/10.12688/wellcomeopenres.16967.2 Text en Copyright: © 2022 Quinn CM et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Quinn, Carson M
Kasibante, John
Namudde, Alice
Bangdiwala, Ananta S
Kabahubya, Mable
Nakasujja, Noeline
Lofgren, Sarah
Elliott, Alison
Boulware, David R
Meya, David B
Cresswell, Fiona V
Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort
title Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort
title_full Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort
title_fullStr Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort
title_full_unstemmed Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort
title_short Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort
title_sort neurocognitive outcomes of tuberculous meningitis in a primarily hiv-positive ugandan cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334841/
https://www.ncbi.nlm.nih.gov/pubmed/35949653
http://dx.doi.org/10.12688/wellcomeopenres.16967.2
work_keys_str_mv AT quinncarsonm neurocognitiveoutcomesoftuberculousmeningitisinaprimarilyhivpositiveugandancohort
AT kasibantejohn neurocognitiveoutcomesoftuberculousmeningitisinaprimarilyhivpositiveugandancohort
AT namuddealice neurocognitiveoutcomesoftuberculousmeningitisinaprimarilyhivpositiveugandancohort
AT bangdiwalaanantas neurocognitiveoutcomesoftuberculousmeningitisinaprimarilyhivpositiveugandancohort
AT kabahubyamable neurocognitiveoutcomesoftuberculousmeningitisinaprimarilyhivpositiveugandancohort
AT nakasujjanoeline neurocognitiveoutcomesoftuberculousmeningitisinaprimarilyhivpositiveugandancohort
AT lofgrensarah neurocognitiveoutcomesoftuberculousmeningitisinaprimarilyhivpositiveugandancohort
AT elliottalison neurocognitiveoutcomesoftuberculousmeningitisinaprimarilyhivpositiveugandancohort
AT boulwaredavidr neurocognitiveoutcomesoftuberculousmeningitisinaprimarilyhivpositiveugandancohort
AT meyadavidb neurocognitiveoutcomesoftuberculousmeningitisinaprimarilyhivpositiveugandancohort
AT cresswellfionav neurocognitiveoutcomesoftuberculousmeningitisinaprimarilyhivpositiveugandancohort